Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: A meta-analysis
- 31 August 2008
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 30 (8) , 1416-1425
- https://doi.org/10.1016/j.clinthera.2008.08.004
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Management of Stable Chronic Obstructive Pulmonary Disease: A Systematic Review for a Clinical Practice GuidelineAnnals of Internal Medicine, 2007
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone–Salmeterol for Treatment of Chronic Obstructive Pulmonary DiseaseAnnals of Internal Medicine, 2007
- Impact of Salmeterol/Fluticasone Propionate versus Salmeterol on Exacerbations in Severe Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Cognitive-behavioural interventions for children who have been sexually abusedPublished by Wiley ,2006
- Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary diseaseEuropean Respiratory Journal, 2003
- Measuring inconsistency in meta-analysesBMJ, 2003
- Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2003
- Effectiveness of Fluticasone Propionate and Salmeterol Combination Delivered via the Diskus Device in the Treatment of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2002